April 15 -17, 2025
Hyatt Regency | Indianapolis, IndianaFollow us for updates & more information!
Human Papillomavirus (HPV) is known to cause six types of cancers in all genders. Despite availability of a vaccine, the U.S. continues to see an alarming rate of HPV transmission and HPV-related cancers. Professionals at the national, regional, state, and local levels are working tirelessly on evidence-based practices and want to collaborate with others to increase prevention, early detection, and treatment of HPV-related diseases.
The goal of this inaugural conference is to invite all U.S. professionals working in the HPV space to come together in an effort to learn and share. While many conferences strive to include HPV as one of many topics, this conference seeks to make HPV the main topic. Attendees will enjoy learning and connecting with peers, while forming new ideas and partnerships to make their own HPV-related efforts stronger.
Together, we can strive to eliminate HPV-related diseases and cancers in the U.S.
Hosted By
National Planning Committee
These partners are working to make the National HPV Conference a more comprehensive and valuable experience for all participants.
The national planning committee consists of members from:
- American Cancer Society
- American Cancer Society National Roundtable on Cervical Cancer
- American Cancer Society National HPV Vaccination Roundtable
- Centers for Disease Control and Prevention
- Global Initiative Against HPV and Cervical Cancer
- Indiana Immunization Coalition
- National Cancer Institute
- National Council of Negro Women
- Recurrent Respiratory Papillomatosis Foundation
- St. Jude Children’s Research Hospital
- Unity Consortium
About the Conference
Expected Outcomes
The National HPV Conference was established to create a venue for networking, dissemination of best practices, resource sharing, and cross collaboration in a way never done before in the United States. We are excited for the opportunity to have HPV champions across key sectors convene together to advance HPV prevention efforts nationally. This inaugural conference will allow participants to:
- Connect with like-minded people from across the country
- Share and learn from others’ experiences
- Stimulate new ideas
- Identify ways to collaborate locally and across state lines
- Develop actionable work plans to implement at home
- Unite in efforts to achieve our central goal of eliminating HPV infections in the U.S.
Intended Audience
The intended audience for this conference is wide-reaching by design. The goal of the conference is to convene professionals who work in many different areas of the HPV continuum in an effort to create partnerships and collaboration. During this inaugural conference, we anticipate 350-500 attendees. The gathering is specifically aimed at professionals in the U.S. who work in and with the public regarding HPV. Some examples of these professionals are:
Guest Speakers
Keynote Speaker
Robin Vanderpool, DrPH
Robin C. Vanderpool, Dr.P.H., is chief of the Health Communication and Informatics Research Branch (HCIRB) in the Division of Cancer Control and Population Sciences at the National Cancer Institute (NCI). Dr. Vanderpool’s scientific background includes both formative and interventional research on HPV vaccination, cancer screening, cancer survivorship, implementation science, and rural cancer control.
Keynote Speaker
Dr. Shannon Stokley
Dr. Stokley serves as acting deputy director for the immunization services division of the National Centers for Immunization and Respiratory Disease at the Centers for Disease Control and prevention. She has over 20 years of experience implementing and evaluating strategies to improve vaccination uptake among adolescent and would provide crucial input into this research project. Furthermore, she is conducting her own research to assist and evaluate MyIR, a pilot project that would allow better access to immunization records. Her own research on vaccination uptake efforts and work at the CDC allows her to give this research project valuable feedback.
HPV Survivor Panelist
Tamika Felder, Survivor
Diagnosed with cancer at 25 while working as an award-winning television producer in Washington, D.C., Tamika has spent the rest of her life proving that triumph over tragedy is entirely possible. A cancer survivor, award-winning women’s health advocate, and Chief Visionary at Cervivor – a nonprofit dedicated to cervical cancer advocacy and support – Tamika also has a mission to eradicate cancer and shine a spotlight on the patient voice in healthcare.
HPV Survivor Panelist
Jason Mendelsohn, Survivor
Jason, a stage IV HPV-attributed tonsil cancer survivor, made the decision to share his cancer story publicly so that others could learn about HPV oropharyngeal cancer, oral cancer screening, and the HPV vaccine. First diagnosed in May 2014, he underwent a radical tonsillectomy and neck dissection, followed by seven weeks of chemo, radiation and a feeding tube. He launched SupermanHPV.com in September 2017, to inspire, educate and encourage others diagnosed with HPV-attributed oropharyngeal cancer.
HPV Survivor Panelist
Lillian Kreppel, Survivor
Lillian Kreppel knew she had HPV because like many women, she’s had an abnormal Pap. Always diligent about preventive checkups, she saw two doctors when she began having suspicious symptoms and was diagnosed with Stage II anal cancer at 53. After successful treatment that she credits to superb medical care and a rock-solid circle of friends, Lillian dove headfirst into bringing this rare cancer into the spotlight. She serves as a patient ambassador for the Anal Cancer Foundation.
HPV Survivor Panelist
Kim McClellan, Survivor
In 1971 at age five, Kim was diagnosed with Recurrent Respiratory Papillomatosis (RRP), a rare disease that left her barely able to speak or struggling to even breathe. After decades of surgery after surgery, and ultimately a tracheostomy, Kim regained her voice. Now as the President of the Recurrent Respiratory Papillomatosis Foundation, a patient advocacy organization, she is using her voice to fight for recognition, treatment options, and hope for all RRP patients and their families
Focus Tracks
Vaccination and Prevention
This track will focus on measures to prevent HPV infection, including education and awareness, advocacy, policy, vaccination, sexual health, health disparities, and more. Speakers will be encouraged to share programs, practices, and materials that have been successful in the realm of HPV prevention. Participants will leave with new ideas and actionable items.
Research and Best Practices
This track invites area experts and researchers to present findings directly related to public-facing HPV care and prevention. Presentations should not be overly technical, but should privilege projects that include evaluation data, consensus statements, or similar approaches to establishing best practices. Applicable topics might include health equity, best practices, health communication, dissemination, or implementation science.
Cancer Screening and Treatment
This track is focused on the screening and treatment of HPV-related cancers. Innovative and emerging methods, as well as those with high compliance and success, should be discussed. Topics might also include related policy and metrics. As with all tracks, presentations are aimed at those in public-facing environments to aid in understanding and communication.
Public Health and Collaboration
This track is focused on the screening and treatment of HPV-related cancers. Innovative and emerging methods, as well as those with high compliance and success, should be discussed. Topics might also include related policy and metrics. As with all tracks, presentations are aimed at those in public-facing environments to aid in understanding and communication.
Loading...
Click Here for a printer-friendly version of the tentative schedule
Call for Abstracts
Late-Breaker Poster Submission
Additional abstracts for POSTERS ONLY may be submitted by February 7th at 8 PM EST
Submit via Oxford Abstracts: https://app.oxfordabstracts.com/stages/21718/submitter
Overview
This conference is aimed towards those working in HPV prevention, screening, diseases, and cancer control. As such, we are most interested in abstracts that highlight successful projects, collaborations, and demonstrations that will be useful to a variety of stakeholders. Scientific presentations should be limited to the practical applications of such work in addressing HPV disease in our society. For more information about the specific areas we are interested in, please read about the four Focus Tracks below.
Requirements for Competitive Papers and Posters
Abstracts submitted for consideration should reflect new or recent work. Abstracts are limited to 250 words and should not contain charts, figures, references, etc. Abstracts should adequately describe the content and focus of the proposed presentation and follow the general outline of background, methods, results, and conclusions.
Below, you will find details about submitting abstracts. If you have any questions as you complete this process, please contact info@nhpvc.org for general conference questions or contact the program planner directly for abstract submission questions (Katy Head, headkj@iu.edu).
Submission Guidelines
Have the following information ready to submit through the online submission system:
- Author/collaborator names, degrees/title, affiliations, city/state, and email addresses (Please indicate the presenting author.)
- Paper/poster title of up to 20 words of text
- Abstract of up to 250 words of text
- Select which of the four Focus Tracks your abstract most aligns with
In fairness to the competitive submission process, submit your abstract for consideration only if you or one of your collaborators anticipate being able to register for and attend the conference to present your work (or arrange to have someone else present your work in the event that an emergency prevents your attendance).
Abstracts will be submitted to blind peer review and will be evaluated on quality and relevance. Incomplete abstracts will not be reviewed or considered for inclusion in the program.
Focus Tracks for Submissions
- Vaccination & Prevention: This track will focus on measures to prevent HPV infection, including education and awareness, advocacy, policy, vaccination, sexual health, health disparities, and more. Speakers will be encouraged to share programs, practices, and materials that have been successful in the realm of HPV prevention. Participants will leave with new ideas and actionable items.
- Research & Best Practices: This track invites area experts and researchers to present findings directly related to public-facing HPV care and prevention. Presentations should not be overly technical, but should privilege projects that include evaluation data, consensus statements, or similar approaches to establishing best practices. Applicable topics might include health equity, best practices, health communication, dissemination, or implementation science.
- Cancer Screening & Treatment: This track is focused on the screening and treatment of HPV-related cancers. Innovative and emerging methods, as well as those with high compliance and success, should be discussed. Topics might also include related policy and metrics. As with all tracks, presentations are aimed at those in public-facing environments to aid in understanding and communication.
- Public Health & Collaboration: This track seeks to help organizations collaborate and engage to further public health initiatives around HPV. Applicable topics might include health disparities and equity, legislation, policies, examples of successful partnerships, or public health outreach programs.
Timeline
- Deadline for late-breaker poster submission is February 7th, 2025 at 8pm Eastern Standard Time.
- Decisions will be sent out by March 1st
Registration
Regular Ticket: Early $400 / Regular $500 / Late $600
Student Ticket: Early $200 / Regular $250
Early: September 6 – January 15 | Regular: January 16 – March 31 | Late: April 1 – Conference
Scholarships
A limited amount of funding is available to assist with conference expenses.
While any person may apply, preference will be given to the following groups:
- Students
- Early career professionals (less than 5 years working in the field)
- Employees of local government agencies and small nonprofits (less than $1 million budget)
- Attendees from rural, underserved, or disadvantaged communities
Applications will close February 15th and decisions will be announced in early March.
The application is available at https://forms.gle/VpevPnPWjkvFbUTw7
Sponsor or Exhibit
View the prospectus here
Thank you for your sponsorship consideration. This is your opportunity to engage with a targeted audience of professionals eager to make a difference in the HPV arena. Sponsorship not only provides exposure and networking for your organization, but also provides the financial support necessary to offer this conference at a reasonable, accessible price for all attendees.
CONFERENCE LOCATION
Hyatt Regency Indianapolis | 1 S. Capitol Avenue, Indianapolis, IN 46204
The hotel is located in downtown Indianapolis, less than 15 miles from the IND airport. Indiana is known as the “Crossroads of America” due to its central location and ease of accessibility by car or airplane. Downtown Indianapolis features an exciting assortment of restaurants, museums, and cultural attractions, making it a prime conference destination. Find out more about Indianapolis at www.visitindy.com
Use the links below to reserve your room
Government per diem rates are for qualified government employees. ID may be required at check-in.
Conference registration and hotel reservations are separate. Make sure to register for the conference here.